Amyloid transthyretinkardiomyopati
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Transthyretin amyloid cardiomyopathy (ATTR-CM) resulting from deposition of transthyretin amyloid fibrils in the heart is an underrecognised cause of heart failure in the elderly and is associated with a poor life expectancy. The diagnosis can now be made by radionuclide imaging with bone tracers, provided absence of plasma-cell dyscrasia. Recent evidence has suggested a considerable prevalence of ATTR-CM, and effective treatment has become available. This review summarises these new developments, which have ushered a new era in the detection and clinical management of ATTR-CM.
Bidragets oversatte titel | Transthyretin amyloid cardiomyopathy |
---|---|
Originalsprog | Dansk |
Artikelnummer | V11190627 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 182 |
Udgave nummer | 6 |
Antal sider | 5 |
ISSN | 0041-5782 |
Status | Udgivet - 2020 |
Links
- https://ugeskriftet.dk/files/scientific_article_files/2020-01/v11190627_0.pdf
Forlagets udgivne version
ID: 260057439